Depypere H - Search Results

1

Nocturia through the menopausal transition and beyond: a narrative review.

Pauwaert K, Goessaert AS, Ghijselings L, Monaghan TF, Depypere H, Everaert K. Pauwaert K, et al. Among authors: depypere h. Int Urogynecol J. 2021 May;32(5):1097-1106. doi: 10.1007/s00192-020-04640-7. Epub 2021 Jan 13. Int Urogynecol J. 2021. PMID: 33439278 Review.

2

Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial.

Pauwaert K, Goessaert AS, Ghijselings L, Bower W, Mariman A, Vogelaers D, Depypere H, Everaert K. Pauwaert K, et al. Among authors: depypere h. Menopause. 2021 Mar 15;28(5):502-510. doi: 10.1097/GME.0000000000001741. Menopause. 2021. PMID: 33739310 Clinical Trial.

3

Does hormonal therapy affect the bladder or the kidney in postmenopausal women with and without nocturnal polyuria: Results of a pilot trial?

Pauwaert K, Bruneel E, Van Laecke E, Depypere H, Everaert K, Goessaert AS. Pauwaert K, et al. Among authors: depypere h. Maturitas. 2022 Jun;160:61-67. doi: 10.1016/j.maturitas.2022.01.009. Epub 2022 Jan 29. Maturitas. 2022. PMID: 35550708

4

Characterizing nocturia among Belgian healthy postmenopausal women: Prevalence, degree of bother, etiology and risk factors for nocturia.

Pauwaert K, Goessaert AS, Ghijselings L, Bower W, Depypere H, Everaert K. Pauwaert K, et al. Among authors: depypere h. Maturitas. 2021 Jan;143:41-46. doi: 10.1016/j.maturitas.2020.08.008. Epub 2020 Aug 22. Maturitas. 2021. PMID: 33308635

5

The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review.

Depypere H, Inki P. Depypere H, et al. Climacteric. 2015;18(4):470-82. doi: 10.3109/13697137.2014.991302. Epub 2015 Mar 7. Climacteric. 2015. PMID: 25553775 Review.

6

Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.

Depypere H, Pintiaux A, Desreux J, Hendrickx M, Neven P, Marchowicz E, Albert V, Leclercq V, Van den Branden S, Rozenberg S. Depypere H, et al. Maturitas. 2016 Aug;90:24-30. doi: 10.1016/j.maturitas.2016.04.018. Epub 2016 May 7. Maturitas. 2016. PMID: 27282790

7

Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.

Depypere H, Timmerman D, Donders G, Sieprath P, Ramael S, Combalbert J, Hoveyda HR, Fraser GL. Depypere H, et al. J Clin Endocrinol Metab. 2019 Dec 1;104(12):5893-5905. doi: 10.1210/jc.2019-00677. J Clin Endocrinol Metab. 2019. PMID: 31415087 Clinical Trial.

8

Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer.

Vanhoecke B, Derycke L, Van Marck V, Depypere H, De Keukeleire D, Bracke M. Vanhoecke B, et al. Among authors: depypere h. Int J Cancer. 2005 Dec 20;117(6):889-95. doi: 10.1002/ijc.21249. Int J Cancer. 2005. PMID: 15986430 Free article.

9

Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms.

Genazzani A, Panay N, Simoncini T, Depypere H, Mueck A, Egarter C, Biglia N, Fait T, Birkhaeuser M, Skouby SO, Brincat M, Goldstein S, Ruan X, Celis-Gonzales C, Palacios S. Genazzani A, et al. Among authors: depypere h. Gynecol Endocrinol. 2020 Mar;36(3):190-196. doi: 10.1080/09513590.2020.1722994. Epub 2020 Feb 5. Gynecol Endocrinol. 2020. PMID: 32019391 Free article. Review.

10

Alzheimer's disease, apolipoprotein E and hormone replacement therapy.

Depypere H, Vierin A, Weyers S, Sieben A. Depypere H, et al. Maturitas. 2016 Dec;94:98-105. doi: 10.1016/j.maturitas.2016.09.009. Epub 2016 Sep 29. Maturitas. 2016. PMID: 27823753 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page